Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,778 | 486 | 98.3% |
| Education | $135.99 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,284 | 79 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,063 | 63 | $0 (2024) |
| ITI, Inc. | $826.29 | 39 | $0 (2023) |
| Alkermes, Inc. | $643.68 | 38 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $600.79 | 30 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $587.02 | 33 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $495.55 | 27 | $0 (2024) |
| ABBVIE INC. | $475.69 | 36 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $461.00 | 42 | $0 (2024) |
| Lundbeck LLC | $428.63 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,778 | 175 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($600.79) |
| 2023 | $2,959 | 171 | ITI, Inc. ($576.33) |
| 2022 | $1,061 | 66 | ITI, Inc. ($189.84) |
| 2021 | $1,115 | 77 | Alkermes, Inc. ($154.77) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.03 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $0.24 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Central Nervous System | ||||||
| 11/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/23/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 250 | 554 | $60,292 | $38,322 |
| 2022 | 4 | 172 | 344 | $35,049 | $17,930 |
| 2021 | 1 | 47 | 136 | $12,240 | $3,902 |
| 2020 | 1 | 42 | 76 | $6,840 | $1,827 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 100 | 319 | $29,868 | $21,224 | 71.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 83 | 83 | $14,164 | $9,461 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 70 | $8,610 | $4,580 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 82 | $7,650 | $3,057 | 40.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 49 | 164 | $15,355 | $9,303 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 101 | $9,140 | $3,927 | 43.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 36 | 36 | $6,099 | $3,477 | 57.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $1,755 | $978.81 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 29 | 30 | $2,700 | $243.60 | 9.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 47 | 136 | $12,240 | $3,902 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 42 | 76 | $6,840 | $1,827 | 26.7% |
About Constance Jacob, APRN
Constance Jacob, APRN is a Nurse Practitioner healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2019. The National Provider Identifier (NPI) number assigned to this provider is 1639729726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Constance Jacob, APRN has received a total of $7,914 in payments from pharmaceutical and medical device companies, with $2,778 received in 2024. These payments were reported across 489 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,778).
As a Medicare-enrolled provider, Jacob has provided services to 511 Medicare beneficiaries, totaling 1,110 services with total Medicare billing of $61,982. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Wichita, KS
- Active Since 09/19/2019
- Last Updated 09/19/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1639729726
Products in Payments
- CAPLYTA (Drug) $1,427
- REXULTI (Drug) $1,374
- INVEGA SUSTENNA (Drug) $1,052
- ARISTADA (Drug) $609.03
- HETLIOZ (Drug) $495.55
- VRAYLAR (Drug) $475.69
- INGREZZA (Drug) $461.00
- Austedo XR (Drug) $263.63
- TRINTELLIX (Drug) $228.58
- LATUDA (Drug) $183.92
- PERSERIS (Drug) $175.39
- Auvelity (Drug) $166.95
- ABILIFY MAINTENA (Drug) $163.67
- AUSTEDO (Drug) $163.25
- UZEDY (Drug) $160.14
- NUEDEXTA (Drug) $123.42
- Dayvigo (Drug) $101.47
- ABILIFY ASIMTUFII (Drug) $90.14
- BELSOMRA (Drug) $53.95
- LYBALVI (Drug) $34.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Wichita
Ms. Catherine Woods, Aprn, APRN
Nurse Practitioner — Payments: $49,709
Kristin Miller, Aprn, APRN
Nurse Practitioner — Payments: $44,574
Darine Jamaleddine, Aprn, APRN
Nurse Practitioner — Payments: $13,944
Christina Stanton, Aprn, APRN
Nurse Practitioner — Payments: $8,328
Amanda Mogoi, Aprn, APRN
Nurse Practitioner — Payments: $7,931
Sarah Rooker
Nurse Practitioner — Payments: $7,738